Biotech Business Hansa Biopharma announces temporary marketing authorization in Switzerland Malin Otmani May 13, 2022
New Market InDex Pharmaceuticals prepares for commercialization of cobitolimod Malin Otmani April 1, 2022
Biotech Business 200 Views Immunovia Inc achieves Clinical Laboratory Licensure Malin Otmani May 18, 2022 The Rhode Island Department of…
Biotech Business 104 Views Hansa Biopharma announces temporary marketing authorization in Switzerland Malin Otmani May 13, 2022 Hansa Biopharma has announces that…
New Market 318 Views Novo Nordisk’s Ozempic 2.0 mg approved in the US Malin Otmani April 4, 2022 Novo Nordisk has announced that…
New Market 289 Views InDex Pharmaceuticals prepares for commercialization of cobitolimod Malin Otmani April 1, 2022 InDex Pharmaceuticals Holding is planning…
New Market 405 Views AstraZeneca’s Ondexxya approved in Japan Malin Otmani March 29, 2022 Ondexxya has been approved in…
New Market 597 Views AstraZeneca’s Tezspire approved in the US Malin Otmani December 20, 2021 AstraZeneca and Amgen’s Tezspire has…
Biotech Business 798 Views FDA approves Calliditas’ TARPEYO Malin Otmani December 16, 2021 Calliditas Therapeutics has announced that…
New Market 465 Views AstraZeneca’s Saphnelo approved in Japan for SLE Malin Otmani September 28, 2021 Saphnelo (anifrolumab) has been approved…
New Market 727 Views AstraZeneca’s Forxiga approved in Japan Malin Otmani September 1, 2021 AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose…
MedTech Business 827 Views Photocure regains rights to Cysview in Canada Malin Otmani August 31, 2021 Photocure has reached agreement with…
MedTech Business 988 Views Immunovia Inc to begin patient testing in the US Malin Otmani August 4, 2021 Immunovia, Inc has received final…
Biotech Business 767 Views Hansa Biopharma announces reimbursement in the Netherlands of Idefirix Malin Otmani August 2, 2021 Hansa Biopharma has announced that…
New Market 637 Views AstraZeneca’s Orpathys approved in China Malin Otmani June 23, 2021 AstraZeneca and HUTCHMED’s Orpathys has…
New Market 1 COMMENT 831 Views Elypta launches research service for glycosaminoglycan profiling Malin Otmani February 4, 2021 Elypta has announced the launch…
New Market 661 Views Oasmia secures IP rights in Australia and Brazil Malin Otmani January 19, 2021 The XMeNa patent protects an…
In a new job 898 Views Nanoform expands its global commercial team Malin Otmani September 7, 2020 Nanoform has appointed Eric Peter…